Menu
Currency
GWAS Study

A genetic variant conferred high expression of CAV2 promotes pancreatic cancer progression and associates with poor prognosis.

Zhu Y, Tian J, Peng X et al.

33975060 PubMed ID
GWAS Study Type
1070 Participants
107 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

ZY
Zhu Y
TJ
Tian J
PX
Peng X
WX
Wang X
YN
Yang N
YP
Ying P
WH
Wang H
LB
Li B
LY
Li Y
ZM
Zhang M
CY
Cai Y
LZ
Lu Z
NS
Niu S
LY
Li Y
ZR
Zhong R
CJ
Chang J
MX
Miao X
Chapter II

Abstract

Summary of the research findings

Aim: This study aimed to identify the functional genes and genetic variants associated with the prognosis of pancreatic ductal adenocarcinoma (PDAC) and reveal the mechanism underlying their prognostic roles.

518 Han Chinese ancestry cases

Chapter III

Study Statistics

Key metrics and study information

1070
Total Participants
GWAS
Study Type
Yes
Replicated
552 Han Chinese ancestry cases
Replication Participants
East Asian
Ancestry
China
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.